Furthermore, it showed that menadione, a special inhibitor of CDC25B, could significantly inhibit HNSCC cell growth with an increase of treatment times and doses (Fig. 4E, Additional file 5: Figure S4E). The gene discussed is CDC25B; the disease is head and neck squamous cell carcinoma.